Atara Biotherapeutics CEO Isaac Ciechanover's 2019 pay jumps 31% to $8M
Atara Biotherapeutics reports 2019 executive compensation
By ExecPay News
Published: April 22, 2020
Atara Biotherapeutics reported fiscal year 2019 executive compensation information on April 22, 2020.
In 2019, six executives at Atara Biotherapeutics received on average a compensation package of $4.2M, which is about the same as previous year.
Average pay of disclosed executives at Atara Biotherapeutics
Isaac E. Ciechanover, Chief Executive Officer, received $8M in total, which increased by 31% compared to 2018. 73% of Ciechanover's compensation, or $5.9M, was in stock awards. Ciechanover also received $879K in option awards, $384K in salary, as well as $889K in other compensation.
Pascal Touchon, Chief Executive Officer, received a compensation package of $6.6M. 46% of the compensation package, or $3M, was in option awards.
Dietmar Berger, Former Global Head of Research & Development, earned $3.2M in 2019, a 35% decrease compared to previous year.
Joseph Newell, EVP, Chief Technical Operations Officer, received $2.7M in 2019, which increases by 9% compared to 2018.
Utpal Koppikar, Chief Financial Officer, earned $2.5M in 2019, a 40% decrease compared to previous year.
Mina Kim, General Counsel, received $2.3M in 2019, which decreases by 31% compared to 2018.
Related executives
Pascal Touchon
Atara Biotherapeutics
Chief Executive Officer
Utpal Koppikar
Atara Biotherapeutics
Chief Financial Officer
Joseph Newell
Atara Biotherapeutics
EVP, Chief Technical Operations Officer
Isaac Ciechanover
Atara Biotherapeutics
Chief Executive Officer
Dietmar Berger
Atara Biotherapeutics
Former Global Head of Research & Development
Mina Kim
Atara Biotherapeutics
General Counsel
You may also like
Source: SEC filing on April 22, 2020.